Evidence map›Paper›PMID 42722644›Full record

ArticleNature communications2026

Engineered polymerase-mediated efficient synthesis of site-specifically functionalized RNA and 2'-modified RNA oligonucleotides via genetic alphabet expansion.

Jing Wu, Junyan Mei, Zhipeng Chen, Xinyu Shao, Yaxin Wang, Ziqian Xiao, Yuhui Du, Tingjian Chen

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jing Wu *MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.
Junyan Mei *MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.ORCID http://orcid.org/0009-0003-4349-2375
Zhipeng Chen *MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.
Xinyu ShaoMOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.
Yaxin WangMOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.
Ziqian XiaoMOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.
Yuhui DuMOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China.ORCID http://orcid.org/0000-0002-2036-5408
Tingjian ChenMOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, PR China. chentj@scut.edu.cn.ORCID http://orcid.org/0000-0002-4458-4269

Funding

National Natural Science Foundation of China (National Science Foundation of China) 21978100
6 · The paper itself

Abstract

2'-Modified RNA oligonucleotides have found broad use in biotechnology and biomedicine, requiring their efficient synthesis and controllable labelling. While engineered polymerases enable their synthesis, controllable labelling methods remain underdeveloped. Unnatural base pairs (UBPs) have been developed to expand the genetic alphabet, leading to not only the creation of semi-synthetic organisms, but also technologies for site-specific labelling of DNA and RNA. Herein we demonstrate that SFM4-6, an engineered polymerase optimized for 2'-modified RNA oligonucleotide synthesis, can efficiently synthesize unnatural base pair dNaM (2-methoxy-3-(2'-deoxy-β-D-erythro-pentofuranosyl)-naphthalene)-dTPT3 ((2'-deoxy-β-D-erythro-pentofuranosyl)-thieno[3,4]pyridine-2-thione) and its analogues, enabling site-specific incorporation of functionalized unnatural base-containing nucleotides into RNA and 2'-modified RNA oligonucleotides. By combining this with a strategy involving controlled pause and restart of primer extension, we establish methods for producing single or dual-labelled RNA and 2'-modified RNA oligonucleotides. These methods successfully produce various functional labelled RNA and 2'-modified RNA oligonucleotides, highlighting their broad applicability in nucleic acid research and biotechnology.

Indexed as

DNA-Directed DNA PolymeraseOligonucleotidesRNABase PairingDNA-Directed DNA PolymeraseOligonucleotidesRNA

Identifiers

PMID42722644
PMCPMC13562680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.